StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Cash

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Jun 21, 2022 8:13pm

201 Views

Post# 34772691

RE:RE:RE:Cash

none of the bashers will answer that. Some how they haven't released a financing. Looking over last financials it looks more like 866,000 a month so they should have been out of money prior to end of April.

IainCaimbeul wrote: Who knows, maybe Reserve a Call is actually bringing in business.

brad129 wrote: End of March they only had $609,000 how have they continued to operate 2.5 months after while their burn rate was about $750,000 per month?